Santhera Pharmaceuticals Holding AG
SANN
Kedudukan dalam Saham
#16270
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Harga Saham
$18.73
Modal Pasaran
$286.57M
Perubahan (1 hari)
-0.14%
Perubahan (1 tahun)
42.91%
Negara
CH
Perdagangan Santhera Pharmaceuticals Holding AG (SANN)
Kategori
Healthcare
Modal pasaran bagi Santhera Pharmaceuticals Holding AG(SANN)
Modal Pasaran: $286.57M
Sehingga October 2026, Santhera Pharmaceuticals Holding AG mempunyai modal pasaran sebanyak $286.57M. Ini menjadikan Santhera Pharmaceuticals Holding AG syarikat ke-16270th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Santhera Pharmaceuticals Holding AG dari 2014 hingga 2026
SANN berbanding dengan 5 teratas yang paling popular stocks
